8 results
424B3
PHIO
Phio Pharmaceuticals Corp
20 Jun 23
Prospectus supplement
9:30am
and intend to wind down our first-in-human clinical trial for PH-762 in France, which was limited to the treatment of patients with metastatic melanoma
424B5
PHIO
Phio Pharmaceuticals Corp
1 Jun 23
Prospectus supplement for primary offering
5:00pm
and intend to wind down our first-in-human clinical trial for PH-762 in France, which was limited to the treatment of patients with metastatic melanoma
8-K
EX-99.1
PHIO
Phio Pharmaceuticals Corp
16 May 23
Phio Pharmaceuticals Announces FDA Clearance to Initiate
7:35am
will focus its efforts on the U.S. clinical trial and intends to wind down its first-in-human clinical trial for PH-762 in France, which was limited … in cutaneous squamous cell carcinoma, melanoma and Merkel cell, proceeding with the AgonOx, Inc.-sponsored clinical trial and our expected wind-down of our
424B3
PHIO
Phio Pharmaceuticals Corp
16 Aug 13
Prospectus supplement
12:00am
liquidate, dissolve or wind up;
(each, a “Deemed Liquidation Event”), then in each case, no distribution shall be made to the holders of any shares
- Prev
- 1
- Next